news-med.jpg

Evotec and GARDP announce new partnership to discover novel antibiotics

Collaboration explores opportunities to set up antibiotic discovery and development platform and establish a joint pipeline of novel antibiotic assets Discovery efforts will focus on World Health Organisation (“WHO”) priority pathogens

Topics: Corporate, Antibiotic Resistance, Drug Discovery, Gram-negative bacteria, Antibacterial, Evotec, GARDP, WHO Read More

Aptuit's Collaboration with MGH Covered on OneNucleus Spring 2017 Newsletter

Our recent collaboration with Massachusetts General Hospital (MGH) on the identification and validation of novel targets in Gram-negative bacteria is covered in the Spring edition of OneNucleus Newsletter. Read the full article on page 8 with our expert, Antonio Felici.

Topics: Drug design and discovery, Antibiotic Resistance, Gram-negative bacteria, Partner Research Organization, Antibacterial Read More

Bioversys AG and Aptuit Announce Collaboration to Identify Novel Approaches to Treat Serious Infections from Gram-negative Pathogens

Basel, Switzerland and Greenwich, CT – March 7, 2017 - Bioversys AG and Aptuit today announced the start of a joint collaboration aimed at the identification and validation of novel targets and molecules for Gram-negative bacteria. Aptuit and BioVersys hope that innovative approaches can address ...

Topics: Drug design and discovery, Antibiotic Resistance, Drug Discovery, Gram-negative bacteria, Partner Research Organization Read More

Most Read

Posts by Topic